Literature DB >> 21576368

mTOR kinase domain phosphorylation promotes mTORC1 signaling, cell growth, and cell cycle progression.

Bilgen Ekim1, Brian Magnuson, Hugo A Acosta-Jaquez, Jennifer A Keller, Edward P Feener, Diane C Fingar.   

Abstract

The mammalian target of rapamycin complex 1 (mTORC1) functions as an environmental sensor to promote critical cellular processes such as protein synthesis, cell growth, and cell proliferation in response to growth factors and nutrients. While diverse stimuli regulate mTORC1 signaling, the direct molecular mechanisms by which mTORC1 senses and responds to these signals remain poorly defined. Here we investigated the role of mTOR phosphorylation in mTORC1 function. By employing mass spectrometry and phospho-specific antibodies, we demonstrated novel phosphorylation on S2159 and T2164 within the mTOR kinase domain. Mutational analysis of these phosphorylation sites indicates that dual S2159/T2164 phosphorylation cooperatively promotes mTORC1 signaling to S6K1 and 4EBP1. Mechanistically, S2159/T2164 phosphorylation modulates the mTOR-raptor and raptor-PRAS40 interactions and augments mTORC1-associated mTOR S2481 autophosphorylation. Moreover, mTOR S2159/T2164 phosphorylation promotes cell growth and cell cycle progression. We propose a model whereby mTOR kinase domain phosphorylation modulates the interaction of mTOR with regulatory partner proteins and augments intrinsic mTORC1 kinase activity to promote biochemical signaling, cell growth, and cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21576368      PMCID: PMC3133410          DOI: 10.1128/MCB.05437-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  72 in total

1.  Specific activation of mTORC1 by Rheb G-protein in vitro involves enhanced recruitment of its substrate protein.

Authors:  Tatsuhiro Sato; Akio Nakashima; Lea Guo; Fuyuhiko Tamanoi
Journal:  J Biol Chem       Date:  2009-03-19       Impact factor: 5.157

Review 2.  Activation of mTORC1 in two steps: Rheb-GTP activation of catalytic function and increased binding of substrates to raptor.

Authors:  Joseph Avruch; Xiaomeng Long; Yenshou Lin; Sara Ortiz-Vega; Joseph Rapley; Angela Papageorgiou; Noriko Oshiro; Ushio Kikkawa
Journal:  Biochem Soc Trans       Date:  2009-02       Impact factor: 5.407

3.  New insights into mTOR signaling: mTORC2 and beyond.

Authors:  Dario R Alessi; Laura R Pearce; Juan M García-Martínez
Journal:  Sci Signal       Date:  2009-04-21       Impact factor: 8.192

4.  The pharmacology of mTOR inhibition.

Authors:  David A Guertin; David M Sabatini
Journal:  Sci Signal       Date:  2009-04-21       Impact factor: 8.192

5.  Mammalian target of rapamycin complex 1 (mTORC1) activity is associated with phosphorylation of raptor by mTOR.

Authors:  Lifu Wang; John C Lawrence; Thomas W Sturgill; Thurl E Harris
Journal:  J Biol Chem       Date:  2009-04-03       Impact factor: 5.157

6.  An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1.

Authors:  Carson C Thoreen; Seong A Kang; Jae Won Chang; Qingsong Liu; Jianming Zhang; Yi Gao; Laurie J Reichling; Taebo Sim; David M Sabatini; Nathanael S Gray
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

Review 7.  Molecular mechanisms of mTOR-mediated translational control.

Authors:  Xiaoju Max Ma; John Blenis
Journal:  Nat Rev Mol Cell Biol       Date:  2009-04-02       Impact factor: 94.444

Review 8.  Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms.

Authors:  E A Dunlop; A R Tee
Journal:  Cell Signal       Date:  2009-01-08       Impact factor: 4.315

Review 9.  Not all substrates are treated equally: implications for mTOR, rapamycin-resistance and cancer therapy.

Authors:  Andrew Y Choo; John Blenis
Journal:  Cell Cycle       Date:  2009-02-18       Impact factor: 4.534

10.  Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2.

Authors:  Morris E Feldman; Beth Apsel; Aino Uotila; Robbie Loewith; Zachary A Knight; Davide Ruggero; Kevan M Shokat
Journal:  PLoS Biol       Date:  2009-02-10       Impact factor: 8.029

View more
  62 in total

Review 1.  mTOR function and therapeutic targeting in breast cancer.

Authors:  Stephen H Hare; Amanda J Harvey
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

2.  Silencing of tuberin enhances photoreceptor survival and function in a preclinical model of retinitis pigmentosa (an american ophthalmological society thesis).

Authors:  Stephen H Tsang; Lawrence Chan; Yi-Ting Tsai; Wen-Hsuan Wu; Chun-Wei Hsu; Jin Yang; Joaquin Tosi; Katherine J Wert; Richard J Davis; Vinit B Mahajan
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

3.  TDRG1 regulates chemosensitivity of seminoma TCam-2 cells to cisplatin via PI3K/Akt/mTOR signaling pathway and mitochondria-mediated apoptotic pathway.

Authors:  Yu Gan; Yong Wang; Zhengyu Tan; Jun Zhou; Riko Kitazawa; Xianzhen Jiang; Yuxin Tang; Jianfu Yang
Journal:  Cancer Biol Ther       Date:  2016-04-22       Impact factor: 4.742

4.  mTOR inhibitors for treatment of low-risk prostate cancer.

Authors:  Michael A Liss; Lanette Rickborn; John DiGiovanni; Dean Bacich; Linda A DeGraffenried; Manish Parihar; Ian M Thompson; Zelton Dave Sharp
Journal:  Med Hypotheses       Date:  2018-06-05       Impact factor: 1.538

5.  Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation.

Authors:  Arron Sikka; Manjinder Kaur; Chapla Agarwal; Gagan Deep; Rajesh Agarwal
Journal:  Cell Cycle       Date:  2012-04-01       Impact factor: 4.534

6.  A Critical Kinase Cascade in Neurological Disorders: PI 3-K, Akt, and mTOR.

Authors:  Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang; Kenneth Maiese
Journal:  Future Neurol       Date:  2012-11

7.  Estradiol-induced object recognition memory consolidation is dependent on activation of mTOR signaling in the dorsal hippocampus.

Authors:  Ashley M Fortress; Lu Fan; Patrick T Orr; Zaorui Zhao; Karyn M Frick
Journal:  Learn Mem       Date:  2013-02-19       Impact factor: 2.460

8.  Merging high-quality biochemical fractionation with a refined flow cytometry approach to monitor nucleocytoplasmic protein expression throughout the unperturbed mammalian cell cycle.

Authors:  Margit Rosner; Katharina Schipany; Markus Hengstschläger
Journal:  Nat Protoc       Date:  2013-02-28       Impact factor: 13.491

9.  Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (mammalian target of rapamycin) by IκB kinase α (IKKα).

Authors:  Han C Dan; Aaron Ebbs; Manolis Pasparakis; Terry Van Dyke; Daniela S Basseres; Albert S Baldwin
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

10.  Characterization of the Molecular Mechanisms Underlying Glucose Stimulated Insulin Secretion from Isolated Pancreatic β-cells Using Post-translational Modification Specific Proteomics (PTMomics).

Authors:  Taewook Kang; Pia Jensen; Honggang Huang; Gitte Lund Christensen; Nils Billestrup; Martin R Larsen
Journal:  Mol Cell Proteomics       Date:  2017-11-07       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.